Clinical Trials Browser

Interventional × Pancreatic Neoplasms × gastrin immunogen × Clear all

NCT00044031 2014-04-17

Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms